LICA PHARMACEUTICALS ApS: Financial statements 2023
CVR: 25332520
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 234,223 and a net result of DKK 1,731,068 compared with DKK -1,524,785 the year before. That is a decrease of 25.1% compared with the year before. Equity in the 2023 report amounted to DKK 22,363,760. The solvency ratio was 99.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 234,223
- Profit/Loss
- DKK 1,731,068
- Equity
- DKK 22,363,760
- Total Assets
- DKK 22,447,822
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 234 t. | 1.7 mio. | 22.4 mio. | 1 |
| 2022 | - | 313 t. | -1.5 mio. | 20.6 mio. | 1 |
| 2021 | - | 371 t. | 2.6 mio. | 22.2 mio. | 1 |
| 2020 | - | 326 t. | 844 t. | 19.6 mio. | 0 |
| 2019 | - | 280 t. | 2.8 mio. | 18.8 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
LICA PHARMACEUTICALS ApS has published its annual report for 2022. Gross profit came to DKK 312,597, and the net result was DKK -1,524,785.
About LICA PHARMACEUTICALS ApS
LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The company has 1 employee (2013). In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity in the 2025 report amounted to DKK 24,221,286.